KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) EPS (Weighted Average and Diluted) (2021 - 2026)

ClearPoint Neuro's EPS (Weighted Average and Diluted) history spans 8 years, with the latest figure at -$0.27 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 35.0% to -$0.27 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.91, a 30.0% decrease, with the full-year FY2025 number at -$0.9, down 28.57% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.27 in Q4 2025 for ClearPoint Neuro, down from -$0.21 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for CLPT hit a ceiling of -$0.13 in Q1 2021 and a floor of -$0.29 in Q2 2023.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.19 across 5 years, with a median of -$0.18 in 2021.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 61.11% in 2023 and later surged 44.83% in 2024.
  • Tracing CLPT's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.19 in 2021, then rose by 5.26% to -$0.18 in 2022, then dropped by 5.56% to -$0.19 in 2023, then decreased by 5.26% to -$0.2 in 2024, then tumbled by 35.0% to -$0.27 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for CLPT at -$0.27 in Q4 2025, -$0.21 in Q3 2025, and -$0.21 in Q2 2025.